Characterization of the Phosphorylation Status of the Epidermal Growth Factor Receptor in Lung Cancer
碩士 === 國立陽明大學 === 臨床醫學研究所 === 99 === Multiple dys-regulated cell signaling pathways are controlled by rapid protein phosphorylation. Many enzymes and receptors (e.g. tyrosine kinase receptor, EGFR) are switched "on" or "off" by phosphorylation and dephosphorylation. Ligand bindin...
Main Authors: | Yu-Chen Lee, 李毓晨 |
---|---|
Other Authors: | Teh-Ying Chou |
Format: | Others |
Language: | en_US |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/51977772350432439419 |
Similar Items
-
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01) -
The Interplay between p53 and Epidermal Growth Factor Receptor in Lung Cancer
by: Yu-Wei Chang, et al.
Published: (2014) -
Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
by: Vijaya Raj Bhatt, et al.
Published: (2017-06-01) -
Experimental and computational analysis of epidermal growth factor receptor pathway phosphorylation dynamics
by: Kleiman, Laura B
Published: (2010) -
Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives
by: Mauro Zükin
Published: (2012-04-01)